Skip to main content
Premium Trial:

Request an Annual Quote

Steven Pinker, Stephen Pentoney, Joseph Hogan

Premium
Steven Pinker is among the first 10 participants in the Personal Genome Project, led by Harvard University’s George Church, according to the PGP website. Pinker, who initially chose to remain anonymous, is a professor of psychology at Harvard. The PGP website did not say why he now decided to disclose his participation in the project.
 

 
Stephen Pentoney has become vice president of array biochemistry at Illumina, the company said this week. Prior to joining Illumina, he was director of technology management for the molecular diagnostics business center of Beckman Coulter. In the past, he held several research and development positions at Beckman, gaining “significant experience developing automated DNA sequencing chemistry and instrumentation” and other systems. Pentoney holds a PhD in analytical chemistry from the University of California and a BS in chemistry from California State University.
 

 
GE Healthcare CEO Joseph Hogan has left the company to take a position as CEO of the power and automation company ABB. GE has named John Dineen, who until now was CEO of GE Transportation, to fill Hogan’s spot.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.